Financial Daily from THE HINDU group of publications
Tuesday, Dec 20, 2005


Group Sites

Corporate - Announcements

Aurobindo gets 6 ARVs WHO pre-qualified

Our Bureau

Hyderabad , Dec. 19

AUROBINDO Pharma Ltd (APL) has got six more of its ARV (anti retro viral) products onto the World Health Organisation (WHO) pre-qualification list.

The products included are: Efavirenz tablets - 600 mg; Lamivudine oral solution - 10 mg/ml; Lamivudine and Zidovudine tablets - 150/300 mg; Stavudine capsules - 30 mg; Stavudine capsules - 40 mg; and Zidovudine oral solution - 50 mg/5 ml.

Following this inclusion, the total number of the company's ARV products on WHO's pre-qualification list has gone up to 10, according to a press release from the company here today.

The products included previously are Zidovudine tablets 300 mg, Lamivudine tablets 150 mg, Lamivudine tablets 300 mg and Nevirapine tablets 200 mg. tablets.

This is the first time that Efavirenz tablets, an important first-line agent in the treatment of HIV/AIDS, are appearing on the WHO pre-qualification list.

More Stories on : Announcements

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Aurobindo gets 6 ARVs WHO pre-qualified

L&T pockets Rs 1,300-cr order from ONGC
Actis sells trading unit of Nitrex to Danish firm
Hyundai hikes Santro prices
TVS Motor launches 150 cc `Apache' — Targets sales of 25,000 units a month
Ramsarup Industries plans foray into T&D biz
Taj Business Hotels repositions coffee shops
ICSA secures Rs 20-cr order
TAC to issue shares to South Indian Bank
Excellence award for Lucas TVS
Root cause of talent poaching
Rain group to buy US calcined coke outfit for Rs 500 cr
`India witness to heightened M&A activity'
Sona Group approves merger of two cos
JK Cement plans integrated greenfield plant in Karnataka — A joint venture partner may be roped in
Tata Daewoo signs pact with Pak firm
`Investments in Western region beginning to pay off'
NTC arm to take joint venture route for revamp
People Interactive hopeful of Rs 100-cr growth by next year

The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | The Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright 2005, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line